Bone and bones

骨头和骨头
  • 文章类型: Journal Article
    骨髓脂肪细胞(BMAds)影响骨稳态,但机制尚不清楚。这里,我们发现运动抑制骨髓巨噬细胞分泌PCNA钳夹相关因子(PCLAF),从而抑制BMAds衰老,从而缓解骨骼衰老.巨噬细胞中PCLAF的基因缺失抑制了BMAds衰老和延缓骨骼衰老。相比之下,将PCLAF介导的衰老BMAds移植到健康小鼠的骨髓中抑制了骨转换。机械上,PCLAF与ADGRL2受体结合以抑制AKT/mTOR信号传导,其触发BMAs衰老并随后在成骨细胞和破骨细胞之间传播衰老。值得注意的是,我们开发了一种PCLAF中和抗体,并显示了其对老年小鼠骨骼健康的治疗作用。一起,这些发现确定PCLAF是BMAds衰老的诱导剂,并为治疗年龄相关性骨质疏松症提供了有希望的方法.
    Bone marrow adipocytes (BMAds) affect bone homeostasis, but the mechanism remains unclear. Here, we showed that exercise inhibited PCNA clamp-associated factor (PCLAF) secretion from the bone marrow macrophages to inhibit BMAds senescence and thus alleviated skeletal aging. The genetic deletion of PCLAF in macrophages inhibited BMAds senescence and delayed skeletal aging. In contrast, the transplantation of PCLAF-mediated senescent BMAds into the bone marrow of healthy mice suppressed bone turnover. Mechanistically, PCLAF bound to the ADGRL2 receptor to inhibit AKT/mTOR signaling that triggered BMAds senescence and subsequently spread senescence among osteogenic and osteoclastic cells. Of note, we developed a PCLAF-neutralizing antibody and showed its therapeutic effects on skeletal health in old mice. Together, these findings identify PCLAF as an inducer of BMAds senescence and provide a promising way to treat age-related osteoporosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    骨组织工程(BTE)是一种有前途的替代自体骨移植的临床治疗骨缺损,无机/有机复合水凝胶作为BTE支架是当前研究的热点。纳米羟基磷灰石/明胶甲基丙烯酸酯/氧化海藻酸钠(nHAP/GelMA/OSA)的构建,缩写为HGO,复合水凝胶加载骨形态发生蛋白7(BMP7)将提供一个合适的三维微环境,以促进细胞聚集,扩散,和差异化,从而促进骨修复和再生。
    通过将GelMA和OSA组合制备了双重交联的水凝胶,而HGO水凝胶通过掺入不同量的nHAP来配制。对水凝胶进行物理和化学表征,然后评估其生物相容性。BMP7-HGO(BHGO)水凝胶通过将合适浓度的BMP7掺入到HGO水凝胶中来制备。然后通过体外实验并使用大鼠股骨缺损模型验证BHGO水凝胶的成骨潜力。
    nHAP的添加显着改善了水凝胶的物理性质,和10%nHAP的复合水凝胶在所有组中表现出最佳的整体性能。选定浓度的HGO水凝胶用作BMP7负载的载体,并在体内和体外评估其成骨潜力。与空白对照中观察到的结果相比,BHGO水凝胶显示出优异的体外成骨诱导和体内修复骨组织的潜力。BMP7和HGO组。
    使用含有10%HGO的水凝胶似乎有望用于骨组织工程支架,特别是当负载BMP7以增强其成骨潜力时。然而,需要进一步的调查来优化GelMA,OSA,和nHAP比率,随着BMP7的浓度,最大限度地发挥成骨潜力。
    UNASSIGNED: Bone tissue engineering (BTE) is a promising alternative to autologous bone grafting for the clinical treatment of bone defects, and inorganic/organic composite hydrogels as BTE scaffolds are a hot spot in current research. The construction of nano-hydroxyapatite/gelatin methacrylate/oxidized sodium alginate (nHAP/GelMA/OSA), abbreviated as HGO, composite hydrogels loaded with bone morphogenetic protein 7 (BMP7) will provide a suitable 3D microenvironment to promote cell aggregation, proliferation, and differentiation, thus facilitating bone repair and regeneration.
    UNASSIGNED: Dually-crosslinked hydrogels were fabricated by combining GelMA and OSA, while HGO hydrogels were formulated by incorporating varying amounts of nHAP. The hydrogels were physically and chemically characterized followed by the assessment of their biocompatibility. BMP7-HGO (BHGO) hydrogels were fabricated by incorporating suitable concentrations of BMP7 into HGO hydrogels. The osteogenic potential of BHGO hydrogels was then validated through in vitro experiments and using rat femoral defect models.
    UNASSIGNED: The addition of nHAP significantly improved the physical properties of the hydrogel, and the composite hydrogel with 10% nHAP demonstrated the best overall performance among all groups. The selected concentration of HGO hydrogel served as a carrier for BMP7 loading and was evaluated for its osteogenic potential both in vivo and in vitro. The BHGO hydrogel demonstrated superior in vitro osteogenic induction and in vivo potential for repairing bone tissue compared to the outcomes observed in the blank control, BMP7, and HGO groups.
    UNASSIGNED: Using hydrogel containing 10% HGO appears promising for bone tissue engineering scaffolds, especially when loaded with BMP7 to boost its osteogenic potential. However, further investigation is needed to optimize the GelMA, OSA, and nHAP ratios, along with the BMP7 concentration, to maximize the osteogenic potential.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: English Abstract
    Triply periodic minimal surface (TPMS) is widely used because it can be used to control the shape of porous scaffolds precisely by formula. In this paper, an I-wrapped package (I-WP) type porous scaffolds were constructed. The finite element method was used to study the relationship between the wall thickness and period, the morphology and mechanical properties of the scaffolds, as well as to study the compression and fluid properties. It was found that the porosity of I-WP type scaffolds with different wall thicknesses (0.1 ~ 0.2 mm) and periods (I-WP 1 ~ I-WP 5) ranged from 68.01% ~ 96.48%, and the equivalent elastic modulus ranged from 0.655 ~ 18.602 GPa; the stress distribution of the scaffolds tended to be uniform with the increase of periods and wall thicknesses; the equivalent elastic modulus of the I-WP type scaffolds was basically unchanged after the topology optimization, and the permeability was improved by 52.3%. In conclusion, for the I-WP type scaffolds, the period parameter can be adjusted first, then the wall thickness parameter can be controlled. Topology optimization can be combined to meet the design requirements. The I-WP scaffolds constructed in this paper have good mechanical properties and meet the requirements of repairing human bone tissue, which may provide a new choice for the design of artificial bone trabecular scaffolds.
    三周期极小曲面(TPMS)可以通过公式精确地控制多孔支架的形态而被广泛应用。本文构建一种I型包装(I-WP)型多孔支架,采用有限元法研究壁厚和周期与支架形态和力学性能的关系,并进行压缩和流体性能的研究。研究发现,不同壁厚(0.1~0.2 mm)、不同周期(I-WP 1~I-WP 5)的I-WP型支架孔隙率在68.01%~96.48%范围内,等效弹性模量为0.655~18.602 GPa;随着周期和壁厚的增加,支架应力分布趋于均匀;拓扑优化后I-WP型支架等效弹性模量基本不变,渗透性提升52.3%。综上,对于I-WP型支架可以先调控周期参数,后调控壁厚参数,结合拓扑优化来达到设计要求。本文构建的I-WP型支架具有良好的力学性能,且满足修复人体骨组织的需求,为人工骨小梁支架的设计提供一种新选择。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: English Abstract
    OBJECTIVE: To investigate the clinical significance of bone metabolic indexes for disease assessment and curative effect monitoring in multiple myeloma (MM) bone disease (MBD) patients with different blood separation results.
    METHODS: A total of 134 newly diagnosed MM patients treated in Cangzhou Hospital of Integrated TCM-WM-Hebei were enrolled and divided into control group [119 cases, serum, colloid and red blood cell (RBC) from top to bottom of sample] and abnormal group (15 cases, serum, mixed layer of RBC and serum, colloid and RBC from top to bottom of sample) according to the results of blood separation. According to the imaging findings, MBD was classified into grade 0-4, grade 0-2 was mild, and grade 3-4 was severe. The MBD grade of patients in the two groups was analyzed. The curative effect of MBD patients after chemotherapy and the changes of blood separation results and bone metabolic indexes before and after treatment were evaluated. The correlation between β2-microglobulin (MG) and bone metabolic indexes was analyzed by Pearson correlation analysis.
    RESULTS: In the control group, there were 69 cases of grade 0-2 and 50 cases of grade 3-4, while in the abnormal group, there were 5 cases of grade 0-2 and 10 cases of grade 3-4, the difference was statistically significant (P < 0.05). The serum β2-MG, β-CTX levels in abnormal group were both significantly higher than those in control group, while the levels of P1NP and osteocalcin (OC) were significantly lower (all P < 0.001). In the control group, there were 95 patients with ≥ partial response (PR) and the blood separation results were not changed, while 24 patients with 0.05). Compared with before treatment, the levels of β-CTX and β2-MG in the control group with unchanged blood separation results were significantly decreased (both P < 0.001), while the levels of P1NP and OC were significantly increased (P < 0.01, P < 0.001), and the level of each index in the patients transformed to abnormal blood separation result after treatment did not significantly change (P >0.05); the levels of β-CTX and β2-MG in the abnormal group transformed to normal blood separation result were significantly decreased (both P < 0.01), while the levels of P1NP and OC were significantly increased (P < 0.001, P < 0.01), and the level of each index in patients with unchanged blood separation results did not significantly change (P>0.05). Pearson correlation analysis showed that serum β2-MG was positively correlated with β-CTX (r =0.709, P < 0.001), and negatively correlated with P1NP and OC (r =-0.410,r =-0.412, both P < 0.001).
    CONCLUSIONS: MBD patients with abnormal blood separation results have higher bone disease grade and poor prognosis, which is closely related to the significant increase of bone resorption index β-CTX level and decrease of bone formation index P1NP and OC levels, leading to more serious bone metabolic homeostasis disorder. The results of blood separation combined with the changes of bone metabolic indexes can be used as one of the comprehensive predictors of disease condition, efficacy monitoring and prognosis evaluation of MBD patients.
    UNASSIGNED: 不同血液分离结果的多发性骨髓瘤骨病患者骨代谢水平研究.
    UNASSIGNED: 探讨不同血液分离结果的骨髓瘤骨病(MBD)患者骨代谢指标对病情评估及疗效监测的临床意义。.
    UNASSIGNED: 纳入2016年3月至2020年3月河北省沧州中西医结合医院收治的134例初诊MM患者,根据血液离心结果,分为对照组119例(样本自上而下依次为血清、胶体、红细胞),异常组15例(样本自上而下依次为血清、红细胞、胶体、红细胞),根据影像学表现将MBD分为0-4级,0-2级为骨病较轻者,3-4级为骨病较重者,分析两组患者MBD的分级情况,并对不同血液分离结果的MBD患者进行疗效评价,分析治疗前后血液分离结果及骨代谢指标水平的变化,采用Pearson相关分析法分析β2-微球蛋白(MG)与骨代谢指标水平的相关性。.
    UNASSIGNED: 对照组0-2级69例,3-4级50例;异常组0-2级5例,3-4级10例,比较差异具有统计学意义(P < 0.05)。异常组血清β2-MG、Ⅰ型胶原羧基端肽β特殊序列(β-CTX)水平显著高于对照组,而Ⅰ型前胶原氨基端前肽(P1NP)、骨钙素(OC)水平显著低于对照组(均P < 0.001)。对照组95例疗效≥部分缓解(PR),其血液分离结果未改变;24例疗效< PR,其中5例血液分离结果转为异常。异常组9例疗效≥PR,血液分离结果均转为正常;6例疗效< PR,其中5例血液分离结果仍为异常。与治疗前相比,对照组疗效≥PR的患者β-CTX、β2-MG水平显著降低,而P1NP、OC水平显著升高(均P < 0.001);异常组疗效≥PR的患者β-CTX、β2-MG水平亦显著降低(P < 0.001,P < 0.01),而P1NP、OC水平显著升高(P < 0.001,P < 0.01)。两组疗效 < PR的患者各指标水平与治疗前相比无明显变化(P >0.05)。与疗前相比,对照组治疗后血液分离结果未改变的患者β-CTX、β2-MG水平显著降低(均P < 0.001),P1NP、OC水平显著升高(P < 0.01,P < 0.001),而血液分离结果转为异常的患者各指标水平无明显变化(P >0.05);异常组治疗后血液分离结果转为正常的患者β-CTX、β2-MG水平显著降低(均P < 0.01),P1NP、OC水平显著升高(P < 0.001,P < 0.01),而血液分离结果未改变的患者各指标水平无明显变化。Pearson相关分析显示,患者血清β2-MG与β-CTX水平呈正相关(r =0.709,P < 0.001),与P1NP、OC水平呈负相关(r =-0.410、-0.412,均P < 0.001)。.
    UNASSIGNED: 存在血液异常分离结果的MBD患者骨病分级较高、预后较差,与骨吸收指标β-CTX水平显著升高,骨形成指标P1NP、OC水平显著降低,引起更严重的骨代谢动态平衡紊乱密切相关。血液分离结果联合骨代谢指标水平的变化可作为MBD患者病情、疗效监测及预后评估的综合预测指标之一。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:门克斯病(MD)是一种罕见的疾病,继承,多系统铜代谢紊乱.经典Menkes病的特征是血清铜和铜蓝蛋白浓度低,导致全身多种异常,特别是在结缔组织和中枢神经系统。然而,血清铜和铜蓝蛋白水平也不是可靠的诊断生物标志物,因为健康新生儿的浓度较低。特征性影像学表现在Menkes病的诊断中起着重要作用。据我们所知,关于Menkes病的全身影像学表现的报道很少。
    方法:一名4个月大的男性患者反复发作。他有认知能力,知识分子,增长,毛马达,精密运动,和语言发展滞后。患者的血红蛋白和血清铜蓝蛋白水平较低。核磁共振成像,颅内血管弯曲增加,大脑和小脑萎缩,白质变化,并观察到基底神经节异常。平片显示虫骨,肋骨扩口,干phy端刺激,和四肢长骨的骨膜反应。在患者中鉴定出ATP7A基因的致病变异,所以他被确诊为门克斯病.尽管在住院期间进行了对症和支持治疗,但他的症状并未改善。不幸的是,婴儿在出院3个月后死亡。
    结论:全面、直观地了解本病的影像学表现,有助于临床医师明确本病,避免延误护理。
    BACKGROUND: Menkes disease (MD) is a rare, inherited, multisystemic copper metabolism disorder. Classical Menkes disease is characterized by low serum copper and ceruloplasmin concentrations, leading to multiple abnormalities in the whole-body, especially in connective tissue and central nervous system. However, serum copper and ceruloplasmin levels are not reliable diagnostic biomarkers due to the low concentrations in healthy newborns either. The featured imaging manifestations play an important role in diagnosing Menkes disease. To our knowledge, there are few reports on the systemic imaging manifestations of Menkes disease.
    METHODS: A 4-month-old male patient presented with recurrent seizures. He had cognitive, intellectual, growth, gross motor, precision movement, and language developmental lags. The patient\'s hemoglobin and serum ceruloplasmin level were low. On MRI, increased intracranial vascular tortuosity, cerebral and cerebellar atrophy, white matter changes, and basal ganglia abnormalities were observed. Plain radiograph revealed wormian bones, rib flaring, metaphyseal spurring, and periosteal reactions in the long bones of the limbs. A pathogenic variant in ATP7A gene was identified in the patient, so he was confirmed the diagnosis of Menkes disease. His symptoms did not improve despite symptomatic and supportive treatment during his hospitalization. Unfortunately, the infant died 3 months after leaving hospital.
    CONCLUSIONS: A comprehensive and intuitive understanding of the disease\'s imaging manifestations can help clinicians to identify the disease and avoid delays in care.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    人体内的生理过程在大约24小时的周期中被调节,称为昼夜节律。适应环境变化。骨节律在骨骼发育中起关键作用,新陈代谢,矿化,和重塑过程。骨节律表现出细胞特异性,骨骼中的不同细胞显示各种时钟基因的表达。多种环境因素,包括光,喂养,锻炼,和温度,通过交感神经系统和各种激素影响骨骼昼夜节律。骨骼昼夜节律的破坏有助于骨骼疾病的发作,例如骨质疏松症,骨关节炎和骨骼发育不全。相反,当针对骨细胞的昼夜节律时,这些骨骼疾病可以得到有效治疗,包括时钟基因和药物靶标的节律表达。在这次审查中,我们描述了各种骨细胞生理活动中独特的昼夜节律。然后,我们总结了使骨骼昼夜节律与潜在机制同步的因素。根据审查,我们旨在全面了解骨骼昼夜节律,并总结骨骼疾病的新预防和治疗策略。
    Physiological processes within the human body are regulated in approximately 24-h cycles known as circadian rhythms, serving to adapt to environmental changes. Bone rhythms play pivotal roles in bone development, metabolism, mineralization, and remodeling processes. Bone rhythms exhibit cell specificity, and different cells in bone display various expressions of clock genes. Multiple environmental factors, including light, feeding, exercise, and temperature, affect bone diurnal rhythms through the sympathetic nervous system and various hormones. Disruptions in bone diurnal rhythms contribute to the onset of skeletal disorders such as osteoporosis, osteoarthritis and skeletal hypoplasia. Conversely, these bone diseases can be effectively treated when aimed at the circadian clock in bone cells, including the rhythmic expressions of clock genes and drug targets. In this review, we describe the unique circadian rhythms in physiological activities of various bone cells. Then we summarize the factors synchronizing the diurnal rhythms of bone with the underlying mechanisms. Based on the review, we aim to build an overall understanding of the diurnal rhythms in bone and summarize the new preventive and therapeutic strategies for bone disorders.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    本研究引入了一种多参数设计方法,以创建具有预定义几何特征的三重周期性最小表面(TPMS)支架。水平设定常数和晶胞长度与目标孔隙率和最小孔径系统地相关。以钻石为特色的网络和板材脚手架,陀螺,并生成原始水平集结构。三种径向分级方案应用于六种脚手架类型中的每一种,适应孔隙度和孔径的径向变化。进行计算机模拟以评估18种支架模型的生物力学性能。结果表明,金刚石和陀螺支架比原始支架具有更广阔的设计范围。虽然原始支架显示出最高的杨氏模量和渗透率,它们较低的屈服强度和间充质干细胞(MSC)粘附使它们不适合作为骨支架。甲状腺支架表现出优异的机械和渗透性性能,尽管MSC的附着力略低于金刚石支架。薄板脚手架,以更均匀的材料分布为特征,在各个方向表现出卓越的机械性能,尽管渗透率略低。片状支架的较高比表面积有助于提高MSC粘附性。刺激因素分析还揭示了片状支架优于网状支架的分化潜力。金刚石片类型证明了最佳的差异化。引入径向等级以径向机械性能为代价增强了轴向机械性能。径向降低孔隙度显示出最高的渗透率,MSC附着力,和差异化能力,符合人体骨骼的结构特征。这项研究强调了平衡用于骨组织工程的TPMS支架的各种生物力学特性的关键需求。
    This study introduces a multi-parameter design methodology to create triply periodic minimal surface (TPMS) scaffolds with predefined geometric characteristics. The level-set constant and unit cell lengths are systematically correlated with targeted porosity and minimum pore sizes. Network and sheet scaffolds featuring diamond, gyroid, and primitive level-set structures are generated. Three radially graded schemes are applied to each of the six scaffold type, accommodating radial variations in porosity and pore sizes. Computer simulations are conducted to assess the biomechanical performance of 18 scaffold models. Results disclose that diamond and gyroid scaffolds exhibit more expansive design ranges than primitive counterparts. While primitive scaffolds display the highest Young\'s modulus and permeability, their lower yield strength and mesenchymal stem cell (MSC) adhesion render them unsuitable for bone scaffolds. Gyroid scaffolds demonstrate superior mechanical and permeability performances, albeit with slightly lower MSC adhesion than diamond scaffolds. Sheet scaffolds, characterized by more uniform material distribution, exhibit superior mechanical performance in various directions, despite slightly lower permeability. The higher specific surface area of sheet scaffolds contributes to elevated MSC adhesion. The stimulus factor analysis also revealed the superior differentiation potential of sheet scaffolds over network ones. The diamond sheet type demonstrated the optimal differentiation. Introducing radial gradations enhances axial mechanical performance at the expense of radial mechanical performance. Radially decreasing porosity displays the highest permeability, MSC adhesion, and differentiation capability, aligning with the structural characteristics of human bones. This study underscores the crucial need to balance diverse biomechanical properties of TPMS scaffolds for bone tissue engineering.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    最近,环境温度已被证明可以调节骨骼稳态。然而,冷暴露影响骨量的机制尚不清楚。在我们目前的研究中,我们观察到暴露于低温(CT)会降低小鼠的骨量和质量。此外,来自暴露于低温的小鼠血浆的外泌体的移植(CT-EXO)也可以损害BMSCs的成骨分化,并通过抑制自噬活性来降低骨量。雷帕霉素,一种有效的自噬诱导剂,可以逆转冷暴露或CT-EXO诱导的骨丢失。微阵列测序显示冷暴露增加了CT-EXO中的miR-25-3p水平。机制研究表明miR-25-3p可抑制BMSCs的成骨分化和自噬活性。结果表明,抑制外泌体释放或下调miR-25-3p水平可以抑制CT诱导的骨丢失。这项研究确定了CT-EXO通过miR-25-3p通过靶向SATB2抑制自噬来介导CT诱导的骨质疏松效应,提出了低温对骨量影响的新机制。
    Recently, environmental temperature has been shown to regulate bone homeostasis. However, the mechanisms by which cold exposure affects bone mass remain unclear. In our present study, we observed that exposure to cold temperature (CT) decreased bone mass and quality in mice. Furthermore, a transplant of exosomes derived from the plasma of mice exposed to cold temperature (CT-EXO) can also impair the osteogenic differentiation of BMSCs and decrease bone mass by inhibiting autophagic activity. Rapamycin, a potent inducer of autophagy, can reverse cold exposure or CT-EXO-induced bone loss. Microarray sequencing revealed that cold exposure increases the miR-25-3p level in CT-EXO. Mechanistic studies showed that miR-25-3p can inhibit the osteogenic differentiation and autophagic activity of BMSCs. It is shown that inhibition of exosomes release or downregulation of miR-25-3p level can suppress CT-induced bone loss. This study identifies that CT-EXO mediates CT-induced osteoporotic effects through miR-25-3p by inhibiting autophagy via targeting SATB2, presenting a novel mechanism underlying the effect of cold temperature on bone mass.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    Aging is an inevitable physiological process, often accompanied by age-related bone loss and subsequent bone-related diseases that pose serious health risks. Research on skeletal diseases caused by aging in humans is challenging due to lengthy study durations, difficulties in sampling, regional variability, and substantial investment. Consequently, mice are preferred for such studies due to their similar motor system structure and function to humans, ease of handling and care, low cost, and short generation time. In this review, we present a comprehensive overview of the characteristics, limitations, applicability, bone phenotypes, and treatment methods in naturally aging mice and prematurely aging mouse models (including SAMP6, POLG mutant, LMNA, SIRT6, ZMPSTE24, TFAM, ERCC1, WERNER, and KL/KL-deficient mice). We also summarize the molecular mechanisms of these aging mouse models, including cellular DNA damage response, senescence-related secretory phenotype, telomere shortening, oxidative stress, bone marrow mesenchymal stem cell (BMSC) abnormalities, and mitochondrial dysfunction. Overall, this review aims to enhance our understanding of the pathogenesis of aging-related bone diseases.
    衰老是一个不可避免的生理过程。随着年龄的增长,骨骼常伴随着年龄相关性的骨质流失,进而发生一系列严重威胁人体健康的骨相关疾病。如果以人作为研究对象进行衰老引起的骨骼疾病的研究,将面临着研究时间长、采样不方便、受区域因素影响较大、投入大等问题。小鼠运动系统的结构和功能与人类相似,控制简单,易于获取,成本低,生成时间短,是相对其他实验动物更适合研究衰老对骨骼系统影响的研究对象。因此,该文就自然衰老小鼠和早衰小鼠 (包括 SAMP6小鼠、POLG小鼠、 LMNA小鼠、 SIRT6小鼠、 ZMPSTE24小鼠、 TFAM小鼠、 ERCC1小鼠、 WERNER小鼠和 KL/KL缺陷小鼠)的特点、局限性、应用范围、骨表型及治疗方法进行综述。另外,该文也对上述衰老小鼠模型的作用机制进行了总结,包括细胞DNA损伤反应、衰老相关分泌表型、端粒缩短、氧化应激、骨髓干细胞异常和线粒体功能障碍。希望本文的综述能对了解衰老相关骨病的发病机制有所帮助。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    衰老引起的皮肤问题备受关注,海洋胶原蛋白肽已被证明可以改善这些问题,而哺乳动物胶原肽鲜有报道。在这项研究中,从发酵和非发酵鹿骨中提取发酵鹿骨胶原肽(FCP)和非发酵鹿骨胶原肽(NCP),分别,并使用LC-MS/MS技术分析了它们的肽序列和差异蛋白。将它们应用于D-gal诱导的衰老小鼠后,皮肤的水合能力,抗氧化能力,胶原蛋白合成,并对小鼠的降解能力进行了研究。结果表明,FCP和NCP主要是构成Ⅰ型胶原的多肽,和它们的肽段是不同的。体内实验表明,FCP和NCP可以提高衰老小鼠皮肤胶原纤维的丰富度;提高皮肤的水化能力;促进抗氧化相关酶的活性;还表明通过TGF-β和MAPK通路,皮肤胶原蛋白的合成和降解受到调控。这些结果表明,鹿骨胶原蛋白肽可以改善老化引起的皮肤问题,促进衰老小鼠的皮肤水合作用和抗氧化能力,并通过MAPK通路调节胶原蛋白的合成和降解。
    Skin problems caused by aging have attracted much attention, and marine collagen peptides have been proved to improve these problems, while mammalian collagen peptides are rarely reported. In this study, fermented deer bone collagen peptide (FCP) and non-fermented deer bone collagen peptide (NCP) were extracted from fermented and non-fermented deer bone, respectively, and their peptide sequences and differential proteins were analyzed using LC-MS/MS technology. After they were applied to aging mice induced with D-gal, the skin hydration ability, antioxidant ability, collagen synthesis, and degradation ability of the mice were studied. The results show that FCP and NCP are mainly peptides that constitute type Ⅰ collagen, and their peptide segments are different. In vivo experiments show that FCP and NCP can improve the richness of collagen fibers in the skin of aging mice; improve the hydration ability of skin; promote the activity of antioxidant-related enzymes; and also show that through the TGF-β and MAPK pathways, the synthesis and degradation of collagen in skin are regulated. These results show that deer bone collagen peptide can improve skin problems caused by aging, promote skin hydration and antioxidant capacity of aging mice, and regulate collagen synthesis and degradation through the MAPK pathway.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号